Status:
RECRUITING
Epstein-Barr Virus and Cancer Risks
Lead Sponsor:
Sun Yat-sen University
Collaborating Sponsors:
Wuzhou Red Cross Hospital
Zhongshan People's Hospital, Guangdong, China
Conditions:
Cancer
Eligibility:
All Genders
30-69 years
Brief Summary
The goal of this prospective cohort study is to investigate the associations between Epstein-Barr Virus (EBV) antibody levels and the risk of overall and site-specific cancer types in Southern China. ...
Detailed Description
Growing molecular evidence suggests the involvement of EBV in various cancers, however, comprehensive epidemiological evidence is still lacking. In this study, researchers conducted a population-based...
Eligibility Criteria
Inclusion
- Subject residents in Zhongshan or Wuzhou City;
- Subject has no medical record of prevalent cancer;
- Subject has psychical condition and well consciousness, and willingness to accept and cooperate with the study\'s follow-up procedures.
Exclusion
- Subject has heavy cardiovascular, liver, or kidney disease;
- Subject has prevalent cancer.
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
100000 Patients enrolled
Trial Details
Trial ID
NCT06203314
Start Date
August 1 2008
End Date
December 31 2030
Last Update
January 12 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongshan People's Hospital
Zhongshan, Guangdong, China, 528403
2
Wuzhou Red Cross Hospital
Wuzhou, Guangxi, China, 543002